Related Experiment Video
Updated: Jul 14, 2026

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
Differential regulation of estrogen receptor alpha turnover and transactivation by Mdm2 and stress-inducing agents
Vanessa Duong1, Nathalie Boulle, Sylvain Daujat
1Institut National de la Santé et de la Recherche Médicale U540, Montpellier, France.
Abstract:
In mammalian cells, the level of estrogen receptor alpha (ERalpha) is rapidly decreased upon estrogen treatment, and this regulation involves proteasome degradation. Using different approaches, we showed that the Mdm2 oncogenic ubiquitin-ligase directly interacts with ERalpha in a ternary complex with p53 and is involved in the regulation of ERalpha turnover (both in the absence or presence of estrogens). Several lines of evidence indicated that this effect of Mdm2 required its ubiquitin-ligase activity and involved the ubiquitin/proteasome pathway. Moreover, in MCF-7 human breast cancer cells, various p53-inducing agents (such as UV irradiation) or treatment with RITA (which inhibits the interaction of p53 with Mdm2) stabilized ERalpha and abolished its 17beta-estradiol-dependent turnover. Interestingly, our data indicated that ligand-dependent receptor turnover was not required for efficient transactivation. Altogether, our results indicate that the Mdm2 oncoprotein and stress-inducing agents complexly and differentially regulate ERalpha stability and transcriptional activity in human cancer cells.
Insights
The Mdm2 oncoprotein regulates estrogen receptor alpha (ERalpha) stability and turnover in cancer cells. Stress-inducing agents also impact ERalpha, affecting its transcriptional activity.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- Estrogen receptor alpha (ERalpha) levels decrease upon estrogen treatment via proteasome degradation.
- The Mdm2 oncogenic ubiquitin ligase plays a role in regulating ERalpha turnover.
Purpose of the Study:
- To investigate the interaction between Mdm2 and ERalpha.
- To elucidate the role of Mdm2 ubiquitin ligase activity in ERalpha regulation.
- To examine the impact of p53-inducing agents on ERalpha stability.
Main Methods:
- Co-immunoprecipitation to detect protein interactions.
- Ubiquitin ligase assays to assess Mdm2 activity.
- Western blotting to analyze protein levels.
- Treatment of MCF-7 cells with UV irradiation and RITA.
Main Results:
- Mdm2 directly interacts with ERalpha in a ternary complex with p53.
- Mdm2's ubiquitin ligase activity is required for ERalpha turnover via the ubiquitin/proteasome pathway.
- p53-inducing agents and RITA treatment stabilize ERalpha and inhibit its estrogen-dependent turnover.
- Ligand-dependent ERalpha turnover is not essential for transactivation.
Conclusions:
- Mdm2 oncoprotein and stress-inducing agents differentially regulate ERalpha stability and transcriptional activity in human cancer cells.
- The Mdm2-p53-ERalpha axis is a key regulator of ERalpha homeostasis.
- Targeting Mdm2 or p53 pathways may offer therapeutic strategies in ERalpha-driven cancers.
Related Concept Videos
Abnormal Proliferation
Master Transcription Regulators
Regulation of the Unfolded Protein Response
The Unfolded Protein Response
Other Stress Responses in Bacteria
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...

